6615 Stock Overview
Sofiva Genomics Co.,Ltd. provides genetic testing services in Taiwan and internationally.
Snowflake Score | |
---|---|
Valuation | 0/6 |
Future Growth | 0/6 |
Past Performance | 1/6 |
Financial Health | 6/6 |
Dividends | 0/6 |
Sofiva Genomics Co.,Ltd. Competitors
Price History & Performance
Historical stock prices | |
---|---|
Current Share Price | NT$40.65 |
52 Week High | NT$50.00 |
52 Week Low | NT$37.30 |
Beta | 0.16 |
1 Month Change | -1.81% |
3 Month Change | -9.06% |
1 Year Change | 6.27% |
3 Year Change | -23.30% |
5 Year Change | -59.75% |
Change since IPO | -55.33% |
Recent News & Updates
Recent updates
Some Investors May Be Worried About Sofiva GenomicsLtd's (GTSM:6615) Returns On Capital
Apr 14Estimating The Fair Value Of Sofiva Genomics Co.,Ltd. (GTSM:6615)
Mar 18Sofiva Genomics Co.,Ltd. (GTSM:6615) Investors Should Think About This Before Buying It For Its Dividend
Feb 24Should Weakness in Sofiva Genomics Co.,Ltd.'s (GTSM:6615) Stock Be Seen As A Sign That Market Will Correct The Share Price Given Decent Financials?
Jan 27Our Take On The Returns On Capital At Sofiva GenomicsLtd (GTSM:6615)
Jan 07A Look At The Intrinsic Value Of Sofiva Genomics Co.,Ltd. (GTSM:6615)
Dec 15Read This Before Buying Sofiva Genomics Co.,Ltd. (GTSM:6615) For Its Dividend
Nov 24Shareholder Returns
6615 | TW Healthcare | TW Market | |
---|---|---|---|
7D | -0.6% | -2.5% | -2.6% |
1Y | 6.3% | -12.6% | 25.9% |
Return vs Industry: 6615 exceeded the TW Healthcare industry which returned -12.6% over the past year.
Return vs Market: 6615 underperformed the TW Market which returned 25.9% over the past year.
Price Volatility
6615 volatility | |
---|---|
6615 Average Weekly Movement | 3.3% |
Healthcare Industry Average Movement | 3.5% |
Market Average Movement | 4.5% |
10% most volatile stocks in TW Market | 8.4% |
10% least volatile stocks in TW Market | 2.1% |
Stable Share Price: 6615 has not had significant price volatility in the past 3 months.
Volatility Over Time: 6615's weekly volatility (3%) has been stable over the past year.
About the Company
Founded | Employees | CEO | Website |
---|---|---|---|
2012 | n/a | n/a | www.sofivagenomics.com.tw |
Sofiva Genomics Co.,Ltd. provides genetic testing services in Taiwan and internationally. The company offers prenatal services, including thalassemia carrier screening; tests for microdeletion syndromes and single-gene abnormalities; detection of common chromosome abnormalities, selected microdeletions syndromes, and selected skeletal dysplasia genetic mutations; multiple genetic diseases detection; folate metabolism genetic screening; spinal muscular atrophy carrier screening; fragile X syndrome carrier screening; congenital infection screening; risk assessment for early/late-onset preeclampsia; maternal serum screening for down syndrome; and karyotyping.
Sofiva Genomics Co.,Ltd. Fundamentals Summary
6615 fundamental statistics | |
---|---|
Market cap | NT$868.38m |
Earnings (TTM) | NT$11.53m |
Revenue (TTM) | NT$466.80m |
75.3x
P/E Ratio1.9x
P/S RatioIs 6615 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
6615 income statement (TTM) | |
---|---|
Revenue | NT$466.80m |
Cost of Revenue | NT$336.89m |
Gross Profit | NT$129.91m |
Other Expenses | NT$118.38m |
Earnings | NT$11.53m |
Last Reported Earnings
Dec 31, 2023
Next Earnings Date
n/a
Earnings per share (EPS) | 0.54 |
Gross Margin | 27.83% |
Net Profit Margin | 2.47% |
Debt/Equity Ratio | 0% |
How did 6615 perform over the long term?
See historical performance and comparison